Clinical trials
Phase 1 Lung Diseases, Interstitial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Mayo Clinic | 2 |
| Black Tie Medical, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Marilyn Glassberg | 1 |
| Mario Castro, MD, MPH | 1 |
| Maule Stem Cell Research Institute, Inc. | 1 |
| Medical University of South Carolina | 1 |
| NYU Langone Health | 1 |
| University of California, Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 12 |
| Connective Tissue Diseases | 2 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Pulmonary Fibrosis | 2 |
| Scleroderma, Diffuse | 2 |
| Scleroderma, Systemic | 2 |
| Alveolitis, Extrinsic Allergic | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.